Postoperative bleeding after dental extraction among elderly patients under anticoagulant therapy.


Journal

Clinical oral investigations
ISSN: 1436-3771
Titre abrégé: Clin Oral Investig
Pays: Germany
ID NLM: 9707115

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 16 06 2020
accepted: 27 08 2020
pubmed: 3 9 2020
medline: 19 3 2021
entrez: 3 9 2020
Statut: ppublish

Résumé

This study aimed to assess and compare postoperative bleeding occurrence after dental extraction in medically compromised elderly patients under anticoagulant therapy. This retrospective study included medically compromised elderly patients aged ≥ 65 years who were taking apixaban, dabigatran, edoxaban, rivaroxaban, or warfarin and had undergone single or multiple dental extractions. The primary outcome measure was postoperative bleeding occurrence, which was defined as oozing or marked hemorrhage from 24 h to 7 days after dental extraction. Postoperative bleeding occurrence was calculated for each anticoagulant and compared using Fisher's exact test, followed by multiple comparisons. Two hundred thirty-two patients met the inclusion criteria. The highest postoperative bleeding occurrence was recorded for rivaroxaban (12/37: 32.4%), followed by apixaban (8/44: 18.2%), warfarin (17/98: 17.3%), and edoxaban (2/35: 5.7%). Patients taking dabigatran did not present postoperative bleeding (0/18: 0%). Fisher's exact test, followed by multiple comparison tests, revealed a significant among-anticoagulant difference (p = 0.0095). Postoperative bleeding was significantly higher in patients taking rivaroxaban than in those taking edoxaban or dabigatran (p = 0.03088). Within the limitations of this retrospective study design, these findings suggest that different anticoagulants may affect postoperative bleeding occurrence after dental extraction among medically compromised elderly patients. Clinicians should carefully consider postoperative bleeding after dental extraction in patients taking anticoagulant therapy, especially rivaroxaban.

Identifiants

pubmed: 32875384
doi: 10.1007/s00784-020-03559-z
pii: 10.1007/s00784-020-03559-z
doi:

Substances chimiques

Anticoagulants 0
Rivaroxaban 9NDF7JZ4M3

Types de publication

Journal Article

Langues

eng

Pagination

2363-2371

Références

United Nations (2019) Department of Economic and Social Affairs, population division. World population ageing. https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2019-Highlights.pdf . Accessed 4 June 2020
Kwak EJ, Nam S, Park KM, Kim SY, Huh J, Park W (2019) Bleeding related to dental treatment in patients taking novel oral anticoagulants (NOACs): a retrospective study. Clin Oral Investig 23:477–484. https://doi.org/10.1007/s00784-018-2458-2
doi: 10.1007/s00784-018-2458-2 pubmed: 29696419
Shaw J, de Wit C, Le Gal G, Carrier M (2017) Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease. J Thromb Haemost 15:925–930. https://doi.org/10.1111/jth.13670
doi: 10.1111/jth.13670 pubmed: 28296069
Abayon M, Kolokythas A, Harrison S, Elad S (2016) Dental management of patients on direct oral anticoagulants: case series and literature review. Quintessence Int 47:687–696. https://doi.org/10.3290/j.qi.a36325
doi: 10.3290/j.qi.a36325 pubmed: 27574712
Firriolo FJ, Hupp WS (2012) Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients. Oral Surg Oral Med Oral Pathol Oral Radiol 113:431–441. https://doi.org/10.1016/j.oooo.2011.10.005
doi: 10.1016/j.oooo.2011.10.005 pubmed: 22668425
Berton F, Costantinides F, Rizzo R, Franco A, Contarin J, Stacchi C, Maglione M, Visintini E, Di Lenarda A, Di Lenarda R (2019) Should we fear direct oral anticoagulants more than vitamin K antagonists in simple single tooth extraction? A prospective comparative study. Clin Oral Investig 23:3183–3192. https://doi.org/10.1007/s00784-018-2739-9
doi: 10.1007/s00784-018-2739-9 pubmed: 30392079
Rocha AL, Oliveira SR, Souza AF, Travassos DV, Abreu LG, Ribeiro DD, Silva TA (2019) Bleeding assessment in oral surgery: a cohort study comparing individuals on anticoagulant therapy and a non-anticoagulated group. J Craniomaxillofac Surg 47:798–804. https://doi.org/10.1016/j.jcms.2019.01.049
doi: 10.1016/j.jcms.2019.01.049 pubmed: 30792032
Hair JF Jr, Black WC, Babin BJ, Anderson RE (2014) Multiple regression analysis: Pearson new international edition, 7th edn. Pearson Education Limited, Essex
Brennan Y, Gu Y, Schifter M, Crowther H, Favaloro EJ, Curnow J (2020) Dental extractions on direct oral anticoagulants vs. warfarin: the DENTST study. Res Pract Thromb Haemost 4:278–284. https://doi.org/10.1002/rth2.12307
doi: 10.1002/rth2.12307 pubmed: 32110759 pmcid: 7040537
Lababidi E, Breik O, Savage J, Engelbrecht H, Kumar R, Crossley CW (2018) Assessing an oral surgery specific protocol for patients on direct oral anticoagulants: a retrospective controlled cohort study. Int J Oral Maxillofac Surg 47:940–946. https://doi.org/10.1016/j.ijom.2018.03.009
doi: 10.1016/j.ijom.2018.03.009 pubmed: 29653869
Mauprivez C, Khonsari RH, Razouk O, Goudot P, Lesclous P, Descroix V (2016) Management of dental extraction in patients undergoing anticoagulant oral direct treatment: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol 122:e146–e155. https://doi.org/10.1016/j.oooo.2016.06.003
doi: 10.1016/j.oooo.2016.06.003 pubmed: 27554378
Yagyuu T, Kawakami M, Ueyama Y, Imada M, Kurihara M, Matsusue Y, Imai Y, Yamamoto K, Kirita T (2017) Risks of postextraction bleeding after receiving direct oral anticoagulants or warfarin: a retrospective cohort study. BMJ Open 7:e015952. https://doi.org/10.1136/bmjopen-2017-015952
doi: 10.1136/bmjopen-2017-015952 pubmed: 28827248 pmcid: 5629650
Lopez-Lopez JA, Sterne JAC, Thom HHZ, Higgins JPT, Hingorani AD, Okoli GN, Davies PA, Bodalia PN, Bryden PA, Welton NJ, Hollingworth W, Caldwell DM, Savovic J, Dias S, Salisbury C, Eaton D, Stephens-Boal A, Sofat R (2017) Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis. BMJ 359:j5058. https://doi.org/10.1136/bmj.j5058
doi: 10.1136/bmj.j5058 pubmed: 29183961 pmcid: 5704695
Hanken H, Grobe A, Heiland M, Smeets R, Kluwe L, Wikner J, Koehnke R, Al-Dam A, Eichhorn W (2016) Postoperative bleeding risk for oral surgery under continued rivaroxaban anticoagulant therapy. Clin Oral Investig 20:1279–1282. https://doi.org/10.1007/s00784-015-1627-9
doi: 10.1007/s00784-015-1627-9 pubmed: 26498769
Bensi C, Belli S, Paradiso D, Lomurno G (2018) Postoperative bleeding risk of direct oral anticoagulants after oral surgery procedures: a systematic review and meta-analysis. Int J Oral Maxillofac Surg 47:923–932. https://doi.org/10.1016/j.ijom.2018.03.016
doi: 10.1016/j.ijom.2018.03.016 pubmed: 29627150
Morimoto Y, Yokoe C, Imai Y, Sugihara M, Futatsuki T (2016) Tooth extraction in patients taking nonvitamin K antagonist oral anticoagulants. J Dent Sci 11:59–64. https://doi.org/10.1016/j.jds.2015.09.002
doi: 10.1016/j.jds.2015.09.002 pubmed: 30894947
Cabral KP (2013) Pharmacology of the new target-specific oral anticoagulants. J Thromb Thrombolysis 36:133–140. https://doi.org/10.1007/s11239-013-0929-5
doi: 10.1007/s11239-013-0929-5 pubmed: 23645472
Miller SG, Miller CS (2018) Direct oral anticoagulants: a retrospective study of bleeding, behavior, and documentation. Oral Dis 24:243–248. https://doi.org/10.1111/odi.12698
doi: 10.1111/odi.12698 pubmed: 29480605
Kyosaka Y, Owatari T, Inokoshi M, Kubota K, Inoue M, Minakuchi S (2019) Cardiovascular comparison of 2 types of local anesthesia with vasoconstrictor in older adults: a crossover study. Anesth Prog 66:133–140. https://doi.org/10.2344/anpr-66-02-04
doi: 10.2344/anpr-66-02-04 pubmed: 31545671 pmcid: 6759644
Miclotte I, Vanhaverbeke M, Agbaje JO, Legrand P, Vanassche T, Verhamme P, Politis C (2017) Pragmatic approach to manage new oral anticoagulants in patients undergoing dental extractions: a prospective case-control study. Clin Oral Investig 21:2183–2188. https://doi.org/10.1007/s00784-016-2010-1
doi: 10.1007/s00784-016-2010-1 pubmed: 27891570

Auteurs

Masanao Inokoshi (M)

Department of Gerodontology and Oral Rehabilitation, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8549, Japan.

Kazumasa Kubota (K)

Department of Gerodontology and Oral Rehabilitation, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8549, Japan. kuboanph@tmd.ac.jp.

Eijiro Yamaga (E)

Department of Gerodontology and Oral Rehabilitation, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8549, Japan.

Kaori Ueda (K)

Department of Gerodontology and Oral Rehabilitation, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8549, Japan.

Shunsuke Minakuchi (S)

Department of Gerodontology and Oral Rehabilitation, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo, 113-8549, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH